These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11936902)

  • 1. Xenobiotic transporters: another protective mechanism for chemicals.
    Klaassen CD
    Int J Toxicol; 2002; 21(1):7-12. PubMed ID: 11936902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of hepatic transporters by xenobiotic receptors.
    Klaassen CD; Slitt AL
    Curr Drug Metab; 2005 Aug; 6(4):309-28. PubMed ID: 16101571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of rat multidrug resistance protein 2 in plasma and biliary disposition of dibromosulfophthalein after microsomal enzyme induction.
    Johnson DR; Klaassen CD
    Toxicol Appl Pharmacol; 2002 Apr; 180(1):56-63. PubMed ID: 11922777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenobiotic transporters: ascribing function from gene knockout and mutation studies.
    Klaassen CD; Lu H
    Toxicol Sci; 2008 Feb; 101(2):186-96. PubMed ID: 17698509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of typical inducers on olfactory xenobiotic-metabolizing enzyme, transporter, and transcription factor expression in rats.
    Thiebaud N; Sigoillot M; Chevalier J; Artur Y; Heydel JM; Le Bon AM
    Drug Metab Dispos; 2010 Oct; 38(10):1865-75. PubMed ID: 20639433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of microsomal enzyme inducers on biliary and urinary excretion of acetaminophen metabolites in rats. Decreased hepatobiliary and increased hepatovascular transport of acetaminophen-glucuronide after microsomal enzyme induction.
    Gregus Z; Madhu C; Klaassen CD
    Drug Metab Dispos; 1990; 18(1):10-9. PubMed ID: 1970767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and differential localization of xenobiotic transporters in the rat olfactory neuro-epithelium.
    Thiebaud N; Menetrier F; Belloir C; Minn AL; Neiers F; Artur Y; Le Bon AM; Heydel JM
    Neurosci Lett; 2011 Nov; 505(2):180-5. PubMed ID: 22015764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal absorption and metabolism of xenobiotics.
    Chhabra RS
    Environ Health Perspect; 1979 Dec; 33():61-9. PubMed ID: 540626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of antidiabetic preparations on the processes of xenobiotic metabolism].
    Stroev EA; Belkina ZV
    Farmakol Toksikol; 1989; 52(2):74-7. PubMed ID: 2744150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethanol interactions with other cytochrome P450 substrates including drugs, xenobiotics, and carcinogens.
    Djordjević D; Nikolić J; Stefanović V
    Pathol Biol (Paris); 1998 Dec; 46(10):760-70. PubMed ID: 9922992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of perfluordecaline on the activity of phase III xenobiotic transformation enzymes].
    Kalinina EV; Obraztsov VV; Shekhtman DG; Gudkova OV; Kukushkin NI; Saprin AN
    Biokhimiia; 1991 Apr; 56(4):714-7. PubMed ID: 1912074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biliary excretion of xenobiotics.
    Klaassen CD
    CRC Crit Rev Toxicol; 1975 Oct; 4(1):1-30. PubMed ID: 811425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary excretion of drugs: role of ligandin in newborn immaturity and in the action of microsomal enzyme inducers.
    Klaassen CD
    J Pharmacol Exp Ther; 1975 Nov; 195(2):311-9. PubMed ID: 1185600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 0 and phase III transport in various organs: combined concept of phases in xenobiotic transport and metabolism.
    Döring B; Petzinger E
    Drug Metab Rev; 2014 Aug; 46(3):261-82. PubMed ID: 24483608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular, cellular, and tissue impact of depleted uranium on xenobiotic-metabolizing enzymes.
    Gueguen Y; Rouas C; Monin A; Manens L; Stefani J; Delissen O; Grison S; Dublineau I
    Arch Toxicol; 2014 Feb; 88(2):227-39. PubMed ID: 24146111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.
    Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y
    Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xenobiotic metabolism by cultured primary porcine hepatocytes.
    Behnia K; Bhatia S; Jastromb N; Balis U; Sullivan S; Yarmush M; Toner M
    Tissue Eng; 2000 Oct; 6(5):467-79. PubMed ID: 11074934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of microsomal enzyme inducers on carrier-mediated transport systems in isolated rat hepatocytes.
    Eaton DL; Klaassen CD
    J Pharmacol Exp Ther; 1979 Mar; 208(3):381-5. PubMed ID: 430358
    [No Abstract]   [Full Text] [Related]  

  • 19. Time-course activities of Oct1, Mrp3, and cytochrome P450s in cultures of cryopreserved rat hepatocytes.
    Jacobsen JK; Jensen B; Skonberg C; Hansen SH; Badolo L
    Eur J Pharm Sci; 2011 Oct; 44(3):427-36. PubMed ID: 21925601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-regulation of expression of phase II metabolizing enzymes and multidrug resistance-associated protein 2.
    Catania VA; Sánchez Pozzi EJ; Luquita MG; Ruiz ML; Villanueva SS; Jones B; Mottino AD
    Ann Hepatol; 2004; 3(1):11-7. PubMed ID: 15118574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.